全文获取类型
收费全文 | 21545篇 |
免费 | 2127篇 |
国内免费 | 749篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 424篇 |
妇产科学 | 56篇 |
基础医学 | 1167篇 |
口腔科学 | 43篇 |
临床医学 | 2028篇 |
内科学 | 3618篇 |
皮肤病学 | 75篇 |
神经病学 | 366篇 |
特种医学 | 275篇 |
外科学 | 2878篇 |
综合类 | 4994篇 |
现状与发展 | 5篇 |
一般理论 | 1篇 |
预防医学 | 601篇 |
眼科学 | 2820篇 |
药学 | 2355篇 |
18篇 | |
中国医学 | 2635篇 |
肿瘤学 | 45篇 |
出版年
2024年 | 94篇 |
2023年 | 470篇 |
2022年 | 550篇 |
2021年 | 1040篇 |
2020年 | 884篇 |
2019年 | 770篇 |
2018年 | 804篇 |
2017年 | 858篇 |
2016年 | 920篇 |
2015年 | 972篇 |
2014年 | 1585篇 |
2013年 | 1590篇 |
2012年 | 1556篇 |
2011年 | 1624篇 |
2010年 | 1165篇 |
2009年 | 1069篇 |
2008年 | 1063篇 |
2007年 | 1010篇 |
2006年 | 931篇 |
2005年 | 848篇 |
2004年 | 672篇 |
2003年 | 544篇 |
2002年 | 456篇 |
2001年 | 416篇 |
2000年 | 297篇 |
1999年 | 256篇 |
1998年 | 226篇 |
1997年 | 222篇 |
1996年 | 164篇 |
1995年 | 145篇 |
1994年 | 136篇 |
1993年 | 120篇 |
1992年 | 117篇 |
1991年 | 75篇 |
1990年 | 67篇 |
1989年 | 94篇 |
1988年 | 76篇 |
1987年 | 67篇 |
1986年 | 52篇 |
1985年 | 74篇 |
1984年 | 60篇 |
1983年 | 29篇 |
1982年 | 55篇 |
1981年 | 40篇 |
1980年 | 38篇 |
1979年 | 17篇 |
1978年 | 17篇 |
1977年 | 13篇 |
1976年 | 10篇 |
1973年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
目的 研究糖尿病膀胱病变(Diabetic cystopathy,DCP)储尿期尿动力学特征及膀胱感觉功能障碍,为阐明DCP的发病机制提供实验依据。方法 分别以链脲佐菌素(STZ)、蔗糖诱导制作大鼠DCP模型及利尿模型,正常大鼠作对照。采用免疫组化结合图像分析技术观察膀胱感觉神经递质CGRP及其纤维改变;制备离体全膀胱,作膀胱灌注测压观察膀胱顺应性改变;放免法测定逼尿肌舒张信号转导分子cAMP。结果 DCP8周时,膀胱壁尤其是粘膜下层的CGRP及其神经纤维明显减少;离体膀胱测压显示糖尿病膀胱顺应性升高;膀胱舒张作用明显弱于对照组和利尿组,逼尿肌cAMP含量显著低于后者。结论 ①DCP对膀胱功能的损害是多方面的:CGRP为主要递质的粘膜下层膀胱容量感觉纤维明显减少,膀胱顺应性改变是DCP的致病机制之一。②DCP早期即已发生储尿期功能障碍,并且可能是膀胱收缩功能损伤的因素。③非糖尿病性利尿状态(多尿)对膀胱功能构成一定的损害作用,但不是DCP形成的主要原因。提示临床上对糖尿病患者作必要的尿动力学检查能较早发现DCP,有助于保护膀胱功能。 相似文献
62.
Kkay小鼠糖尿病肾病时ICAM-1的表达 总被引:4,自引:1,他引:3
目的:观察糖尿病肾病时(DN)细胞间黏附分子-1(ICAM-1)表达的变化。方法:22~24周龄:Kkay糖尿病鼠(KA)7只和Kkay非糖尿病鼠(KB)8只,测定血糖,以PAS染色观察各组:DN病变;对肾脏ICAM-1表达进行免疫组化染色和半定量图像分析;并以RT-PCR检测。肾脏ICAM-1 mRNA表达水平。结果:KA组出现明显糖尿病肾脏病变,其肾小球硬化指数(GI)240.00,明显高于KB对照组(118.36,P<0.05);免疫组化显示Kkay小鼠ICAM-1的表达与病理变化一致,其ICAM-1阳性着色面积(15.22%)高于对照组(4.38%,P<0.01),KA组ICAM-1 mRNA表达水平也高于KB组。结论:Kkay小鼠出现糖尿病肾病时伴有ICAM-1表达水平的增高,推测ICAM-1在糖尿病肾病发生发展中起一定作用。 相似文献
63.
AIMS: To determine the morbidity, mortality and healthcare costs of intravenous drug-abusing patients with Type 1 diabetes (IVDA-DM), who are admitted to hospital. METHODS: Retrospective case note analysis of admissions, complications and cost estimation over a 6-year period. Each drug-abusing patient (IVDA-DM) (n = 9) was compared with two controls (n = 18) with Type 1 diabetes but without a history of intravenous drug abuse (DM-controls). Admissions were also analysed for patients with intravenous drug abuse, but without Type 1 diabetes (IVDA-controls) (n = 198). Admissions were at a University teaching hospital in Liverpool, UK. DM-controls were drawn from a population attending diabetes outpatient clinics between 1997 and 2002 at the same hospital. The main outcome measures were: the duration and healthcare costs of hospital admissions per year, outpatient attendances per year, glycated haemoglobin (HbA(1c)), weight, micro- and macrovascular complications and mortality. RESULTS: Multiple admissions, mainly related to ketoacidosis, led to marked differences in mean (95% CI) inpatient days per year per patient [IVDA-DM 28.1 (13.6-42.7) vs. DM-control 1.1 (0.2-1.9); P < 0.0001], mean inpatient days per year per patient in critical care bed (IVDA-DM 1.7 (-0.7-4.2) vs. DM-control 0; P < 0.02) and mean costs of admission, per patient per year (pound sterling 7320 vs. pound sterling 230). The IVDA-DM group frequently omitted insulin, were underweight, failed to attend as outpatients and five had died by the end of 2002. The IVDA-controls spent considerably less time in hospital [3.4 (2.8-3.9) days per patient per year]. CONCLUSION: IVDA-DM patients have higher rates of diabetes complications, are admitted more frequently and have a high mortality compared with DM and IVDA-controls. The cost of inpatient care of this small group of patients was considerable. 相似文献
64.
65.
66.
Masanori Hara M.D. Reiko Yoshida M.D. Susumu Inaba M.D. Akira Higuchi M.D. Yoshifumi Suzuki M.D. Toshio Okada M.D. Takakuni Tanizawa M.D. 《Pediatrics international》1991,33(3):335-344
The aim of this study was to assess the significance of C3 deposition in IgA nephropathy in children and adolescents. One hundred and two patients aged 5–21 years (57 male and 45 female) were studied. The findings of C3 deposition were classified into 8 groups by immunofluorescent (IF) pattern and intensity as follows: group MC3+ (N = 12): mesangiocapillary pattern and 3+ in intensity; group MC2+ (N = 13): mesangiocapillary and 2+; group MC1 + (N = 4): mesangiocapillary and 1 +; group M3+ (N = 11): mesangial and 3+; group M2+ (N = 24): mesangial and 2+; group M1 + (N=18): mesangial 1 +; group S (N = 12): only segmentally positive; and group N (N = 8): negative. Histological changes were scored semiquantitatively as an activity index (cellular proliferation, necrosis, interstitial cell infiltration, and cellular crescents) and a chronicity index (mesangial sclerosis, segmental and global glomerular sclerosis, fibrous crescents, adhesion and tubulo-interstitial change). IF findings were scored semiquantitatively and laboratory findings were also studied. The following results were obtained: 1) The scores of total activity index in MC groups were higher than in the M, S or N groups, and the greater the degree of C3 deposition, the higher the score; 2) Such result was not evident in the chronicity index; 3) High IF scores of IgG and IgM were found in the MC3+ and MC2+ groups; 4) Hematuria was more severe in MC3+ and MC2+ than in other groups, and proteinuria was more prominent in the MC than other groups. Thus the degree of C3 deposition was parallel with histological activity and urinary findings. 相似文献
67.
68.
R S Nanra 《Nephrology, dialysis, transplantation》1992,7(5):384-390
Comprehensive renal function tests were performed in 84 patients with analgesic nephropathy, 33 glomerulonephritis patients matched for creatinine clearance, and 30 control subjects. A system of 1-day renal function tests including urine microscopy, creatinine clearance, phenolsulphonphthalein excretion, urine concentration and acidification, and electrolyte excretion, was used. Patients with analgesic nephropathy were found to have significant sterile pyuria and haematuria, even those with mild renal insufficiency, significantly reduced concentrating ability and a distal acidifying defect, and a tendency to impaired sodium conservation. These function defects are consistent with the primary lesion of renal papillary necrosis in analgesic nephropathy; the detection of these defects have implications in patient management. 相似文献
69.
IgA肾病大鼠血清IgA-纤维连接蛋白的检测及意义 总被引:2,自引:0,他引:2
目的 检测IgA肾病大鼠血清IgA-纤维连接蛋白水平,探讨其在IgA肾小球系膜沉积中的作用。方法 肝叶切除后,尾静脉注射脂多糖,制作IgA肾病大鼠模型。应用ELISA法检测血清IgA-纤维连接蛋白聚合物水平,半定量法对系膜IgA免疫荧光强度评分,二者作相关性分析。结果 IgA肾病时,血清IgA-纤维连接蛋白聚合物水平升高,并与系膜IgA沉积呈正相关。结论 IgA肾病时,血清IgA-纤维连接蛋白聚合物水平是升高的,且可能是导致IgA系膜沉积的原因之一。 相似文献
70.
以辣根过氧化物酶(PO)和抗-PO作为免疫沉淀中的抗原和抗体,用光电比色法,对78例小儿肾脏疾病血清补体对免疫沉淀的抑制作用(IIPC)进行了研究,并同时检测补体成分C3、C4。结果,正常对照IIPCOD值为0.505±0.085,急性肾小球肾炎(0.137±0.108)显著降低(P<0.001);慢性肾小球肾炎(0.470±0.053)改变不明显(P>0.05);肾病综合征(0.401±0.038)明显低下(P<0.05)。IIPC低下的发生率依次为急性肾小球肾炎(83%)、肾病综合征(43%)、慢性肾小球肾炎(32%)。表明小儿肾小球疾病时IIPC大多降低并与疾病的活动性有关。因此认为IIPC低下在肾脏病的发生和发展中起一定作用。 相似文献